Following a 30% growth in England over the previous five years, Diabetes medicines spend exceeded £1bn in the financial year 2017/18. Almost 20% of the £1bn spend was on ‘Diagnostic and monitoring’ devices, which mainly consists of Test Strips for Blood Glucose Monitors used in self-monitoring by patients.
Our research and client experience indicates that NHS England could save between £28m and £52m (17% to 32%) per year on Self-Monitoring Blood Glucose Test Strips.
The NHS genomic service could transform medicine